HALO logo
halo search icon
Intellia Therapeutics, Inc.

US$12.37

Price Change Indicator
0.11 (0.897%)
Intellia Therapeutics, Inc.
NTLA · NAS

Intellia Therapeutics, Inc.

Start Trading NTLA for Free

US$12.37

Price Arrow0.11 (0.897%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusALL-RecommendationsBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumHALO Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Intellia Therapeutics, Inc. Overview

NTLA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About NTLA

icon
icon

Telephone

1.857.285.6200

icon

Address

Suite 130, 40 Erie Street, Cambridge, MA 02139

Description

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

NTLA Price Chart

Key Stats

Market Cap

US$1.71B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 6.83 - 28.25

Trade Value (12mth)

US$18,972,092.00

1 week

-10.31%

1 month

-26.01%

YTD

33.12%

1 year

29.6%

All time high

202.73

Key Fundamentals

EPS 3 yr Growth

-38.20%

EBITDA Margin

-628.10%

Operating Cashflow

-$395m

Free Cash Flow Return

-43.90%

ROIC

-45.90%

Interest Coverage

0.00

Quick Ratio

5.10

Other Data

Shares Outstanding (Fully Diluted)

118m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

NTLA Announcements

Latest Announcements

DateAnnouncements
11 May 26
11 May 26
11 May 26
11 May 26
01 May 26

NTLA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-5.42-5.25-3.81locklocklock
EPS (Fully Diluted)
 $locklocklocklock-5.42-5.25-3.81locklocklock
Growth
 %locklocklocklock123.127.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Intellia Therapeutics, Inc. (NTLA:NAS)?
Halo FAQ
The current share price of Intellia Therapeutics, Inc. (NTLA:NAS) is USD$12.37.
What is the 52-week high share price for Intellia Therapeutics, Inc. (NTLA:NAS)?
Halo FAQ
The 52-week high share price for Intellia Therapeutics, Inc. (NTLA:NAS) is USD$28.25.
What is the 52-week low share price for Intellia Therapeutics, Inc. (NTLA:NAS)?
Halo FAQ
The 52-week low share price for Intellia Therapeutics, Inc. (NTLA:NAS) is USD$6.83.
What is the dividend yield for Intellia Therapeutics, Inc. (NTLA:NAS)?
Halo FAQ
Intellia Therapeutics, Inc. (NTLA:NAS) does not pay a dividend.
What was Intellia Therapeutics, Inc. (NTLA:NAS) last dividend payment?
Halo FAQ
Intellia Therapeutics, Inc. (NTLA:NAS) does not pay a dividend.
What is the franking level for Intellia Therapeutics, Inc. (NTLA:NAS)?
Halo FAQ
Intellia Therapeutics, Inc. (NTLA:NAS) has a franking level of 0.00%.
In which sector is Intellia Therapeutics, Inc. (NTLA:NAS) classified?
Halo FAQ
Intellia Therapeutics, Inc. (NTLA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial